Immunome Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMNM is expected to report earnings to rise 19.58% to -62 cents per share on August 13
Q2'25
Est.
$-0.62
Q1'25
Beat
by $0.14
Q4'24
Missed
by $0.45
Q3'24
Missed
by $0.24
Q2'24
Missed
by $0.22
The last earnings report on May 12 showed earnings per share of -51 cents, beating the estimate of -66 cents. With 141.28K shares outstanding, the current market capitalization sits at 701.32M.